Mestinon, Pyridostigmine Bromide, Regonol (pyridostigmine) is a small molecule pharmaceutical. Pyridostigmine was first approved as Mestinon on 1982-01-01. It is used to treat drug-induced abnormalities and myasthenia gravis in the USA. It is known to target acetylcholinesterase and cholinesterase.
|Trade Name||Mestinon, Pyridostigmine Bromide, Regonol|
|Indication||drug-induced abnormalities, myasthenia gravis|
|Drug Class||Cholinesterase inhibitors (physostigmine type)|